Restoring the Guardian of your Genome

There is a gene inside every one of your cells that is working around the clock to make sure those cells do not turn into cancer. It monitors damage, decides whether a cell can be repaired, and when the damage is too far gone, it signals that cell to die before it can cause harm. Without this gene functioning properly, your cells lose one of their most important guardrails. That gene is called TP53, and the protein it produces is called p53. Researchers have been studying it for over four decades, because mutations in TP53 are found in roughly half of all human cancers, more than any other gene.

If you have received a cancer diagnosis or you are doing everything you can to prevent one, understanding what p53 does and what disrupts it gives you a window into your biology that most people never get to look through. Let me walk you through it.

What p53 Actually Does

Think of p53 as the quality control manager inside every cell. Every time your cells divide, and they are dividing constantly, tiny errors can creep into the DNA. Most of the time those errors are harmless. But sometimes they are not, and left unchecked, they can accumulate into the kind of cellular dysfunction that leads to cancer.

P53 reads those errors. When it detects damage, it does one of two things. It either hits the pause button on cell division and directs the cell to repair itself, or, if the damage is too severe to fix, it activates a program of controlled cell death called apoptosis. The cell essentially takes itself out of circulation rather than passing its damaged DNA on to the next generation of cells. This is not a failure. It is the system working exactly as it should.

P53 also plays a major role in how your cells produce energy. Healthy cells generate energy in a clean, efficient way through structures called mitochondria. Cancer cells tend to abandon that process and switch to a far more primitive form of energy production called glycolysis, which ferments glucose even when oxygen is fully available. This phenomenon was first described by German biochemist Otto Warburg nearly a century ago, and we now understand that p53, when functioning properly, actively suppresses this shift. This is one of the reasons your metabolic environment matters so much in cancer prevention and treatment support. Your mitochondria are not just producing energy. They are part of your cancer defense system.

What Happens When TP53 Mutates

A TP53 mutation means the gene has been altered in a way that disrupts p53’s ability to do its job. The quality control manager is compromised. Cells with DNA damage that should have been caught and corrected, or eliminated, instead keep dividing. Over time, that accumulation becomes a serious problem.

Here is something worth understanding that is not always explained clearly. There are two very different reasons you might have a TP53 mutation, and they have completely different implications for you and your family.

The first is called a somatic mutation. This means the mutation developed over time in specific cells, driven by accumulated environmental exposures, chronic inflammation, or the wear of cell division, and it exists only in the cancer itself. This is by far the most common situation. Around half of all cancers carry a somatic TP53 mutation in the tumor cells. It tells your oncologist something meaningful about how your cancer is behaving, but it does not mean the rest of your body’s cells carry that mutation, and it carries no implications for your children.

The second is a germline mutation. This one is inherited. If you have a germline TP53 mutation, it was present from the moment of conception and it exists in every cell in your body. This is the basis of a hereditary cancer syndrome called Li-Fraumeni syndrome. People who carry germline TP53 mutations face a significantly elevated lifetime risk of multiple cancer types, including breast cancer at a young age, soft tissue sarcomas, brain tumors, and adrenocortical cancer. Surveillance in this context is intensive, radiation is approached with particular caution because it carries an elevated risk of triggering new tumors in this population, and family members need to be tested.

If a TP53 mutation has shown up anywhere in your testing and no one has clearly explained which of these two situations applies to you, that conversation needs to happen. A genetic counselor is the right person to help you make sense of it.

The Metabolic Connection

One of the most powerful things you can do when TP53 function is compromised is to address your metabolic environment directly. This is where integrative oncology does its most important work.

When cancer cells switch to the Warburg metabolism and begin fermenting glucose, they become dependent on a constant sugar supply to fuel their growth. An acidic, sugar-rich internal environment is where they thrive. A low-glucose, anti-inflammatory environment with well-functioning mitochondria is where they struggle. You have far more influence over that internal environment than you may have been told.

Reducing refined carbohydrates and sugar directly limits the fuel source that cancer cells are reaching for preferentially. Supporting your mitochondria through targeted nutrition, movement, and sleep gives your healthy cells the metabolic advantage. Managing chronic inflammation through diet, stress physiology work, and lifestyle change is not optional in this picture. It is foundational. These are not gentle wellness suggestions. They are direct interventions into the biological terrain that either support or undermine the environment in which TP53-mutated cancer grows.

Natural Compounds That Support p53

Research into compounds that can support p53 function, stabilize it, or even reactivate it after mutation is one of the more exciting areas in integrative oncology right now. Here is where the evidence is most compelling.

The Cruciferous Vegetables: PEITC and Sulforaphane

Cruciferous vegetables are essential, and not simply because they are “healthy.” They contain two specific compounds that work directly on p53 in ways that matter clinically. Phenethyl isothiocyanate (PEITC), concentrated in watercress, broccoli, and Brussels sprouts, has been shown in research to reactivate mutant p53, restoring its ability to trigger cancer cell death even after it has been altered by mutation. A 2025 study added important depth to this, showing that PEITC can neutralize the harmful gain-of-function activity that certain p53 mutations develop, meaning it addresses not just the loss of p53’s protective function but the active damage a corrupted p53 can do. Sulforaphane, also found in cruciferous vegetables, works by blocking MDM2, the protein that would otherwise degrade p53 too quickly, effectively extending the time p53 stays active and functional in the cell. Eating these vegetables lightly cooked or raw, alongside a small amount of raw mustard seed or daikon radish, significantly increases how much sulforaphane your body can actually absorb.

Fisetin

Fisetin is a flavonoid found in strawberries, apples, cucumbers, and onions, and it deserves far more attention than it typically receives. Research shows that fisetin stabilizes the active form of p53 in cancer cells and activates death signals in those cells, through a process involving a receptor called DR5, while leaving healthy cells largely unaffected. There is also compelling emerging research on its role as a senolytic agent, meaning it may help clear out the damaged, sluggish cells that accumulate after cancer treatment and contribute to ongoing inflammation. If you have been through chemotherapy or radiation, this is a compound worth a focused conversation with your integrative clinician.

Luteolin

Luteolin is a flavonoid found in celery, parsley, chamomile, and thyme, and it acts on p53 through a well-studied mechanism. It activates a signaling molecule called JNK, which then phosphorylates and stabilizes p53, protecting it from the proteasomal degradation that would otherwise reduce its activity. Research in non-small cell lung cancer demonstrated that luteolin directly binds TP53 with high affinity and works through the Akt/MDM2/p53 pathway to induce apoptosis in cancer cells. In high-grade serous ovarian cancer, luteolin was shown to activate p53 phosphorylation at the key sites of serine 15 and serine 46 and suppress tumor growth in patient-derived xenograft models. It also has a particular quality that makes it interesting from a treatment perspective: it has demonstrated the ability to induce apoptosis even in multidrug-resistant cancer cells, working through the ATR/Chk2/p53 pathway to overcome resistance mechanisms.

Curcumin

The evidence for curcumin and p53 is substantial and worth understanding in detail. Research has shown that curcumin increases the half-life of p53 through its interaction with an enzyme called NQO1, which protects p53 from premature degradation and allows it to remain active and tumor-suppressive for longer. Studies in pancreatic cancer cells demonstrated that curcumin can physically bind to and stabilize certain mutant forms of p53, restoring their DNA-binding ability and triggering a cascade of apoptotic activity that the untreated mutant protein could not initiate. Curcumin has also shown the ability to selectively destabilize the harmful gain-of-function version of mutant p53 while leaving the healthy wild-type form unaffected, which is a meaningful distinction in clinical context. Because curcumin has well-documented interactions with certain chemotherapy agents and other treatments, its use during active treatment requires careful clinical guidance. This is a conversation to have directly with your integrative oncologist before adding it to your protocol.

Resveratrol and Quercetin

Resveratrol, found in red grapes and berries, enhances p53 stability and activity through pathways that intersect with cellular stress response signaling. Quercetin, abundant in apples, capers, and red onions, supports p53 function and has demonstrated the ability to interfere with the glycolytic metabolism that cancer cells depend on, making it relevant from both the metabolic and the direct p53-supportive angles.

Vitamin C

The relationship between vitamin C and p53 is one of the most clinically relevant in this entire space. Research has shown that ascorbate activates p53 by promoting MDM2 ubiquitination, effectively freeing p53 from its primary degradation mechanism and allowing it to engage its full tumor-suppressive transcriptional network. Crucially, researchers found that p53-expressing tumors showed stronger inhibition of tumor growth in response to ascorbate than p53-deficient tumors, suggesting that supporting p53 function and administering vitamin C may work synergistically rather than independently. Vitamin C also upregulates p53 and its downstream apoptosis-associated proteins, including p21 and Bax, while downregulating the anti-apoptotic protein Bcl-2. The concentration needed to achieve the most significant effects is pharmacological rather than dietary, which points to intravenous vitamin C as the therapeutically relevant route for oncology applications.

Selenium

Selenium has a long history in cancer prevention research, and its connection to p53 is specific and well-documented. Selenium compounds have been shown to activate the ATM/p53 pathway, the same DNA damage response cascade that triggers p53’s protective functions, and to induce p53-dependent apoptosis in cervical cancer cells. Research has also identified a role for selenium in p53-dependent DNA repair, with selenium-treated cells showing enhanced repair activity that depends on functional p53. Beyond direct p53 effects, selenium is incorporated into selenoproteins that protect cells from oxidative DNA damage, reducing the mutational burden that drives TP53 alteration in the first place. Brazil nuts, sardines, and pasture-raised eggs are among the most bioavailable dietary sources, though selenium has a narrow therapeutic window and optimal dosing should be guided by testing.

Reishi Mushroom

Reishi (Ganoderma lucidum) has earned its place in integrative oncology through a growing body of research that goes well beyond general immune support. In ovarian cancer cells specifically, reishi was shown to induce cell cycle arrest, activate the cell-death enzyme caspase-3, increase p53 expression, and inhibit Akt, a protein that when overactive promotes cancer cell survival. Its beta-glucan polysaccharides demonstrate broad antitumor and immunostimulating activity, and its triterpene compounds have shown the ability to reduce tumor invasion and limit metastasis. Reishi also enhances natural killer cell activity through pathways that include MAPK signaling, giving it a meaningful role in immune surveillance alongside its more direct tumor-suppressive effects.

What You Do Every Day Matters More Than You Think

Exercise is one of the most consistently supported lifestyle interventions in cancer research, and part of the reason is its direct effect on p53. Physical activity triggers the molecular modifications that activate p53’s tumor-suppressive function, reduces chronic inflammation, and supports mitochondrial health across the board. The evidence here is not preliminary. It is robust, and it belongs at the center of any integrative protocol.

Light matters too. Your mitochondria are regulated in part by your circadian rhythm, and morning sunlight is what sets that rhythm in motion. The enzyme that drives efficient mitochondrial energy production, cytochrome c oxidase, is light-sensitive. Getting outside at sunrise and sunset as a deliberate daily practice is not a wellness trend. It is mitochondrial medicine, and it supports the metabolic conditions that keep p53 in a favorable operating environment. When did you last watch the sun come up without looking at your phone?

Cold exposure, whether through cold water immersion or deliberate contrast hydrotherapy, stimulates the creation of new mitochondria, a process called mitochondrial biogenesis, and trains your metabolism toward the kind of flexibility that healthy cells have and cancer cells lack.

The Question Worth Sitting With

P53 is not simply a gene that either works or does not work. It sits at the intersection of your genetics, your metabolism, your inflammation levels, your daily habits, and your environment. Even where a mutation is present, the biological terrain surrounding it determines how aggressively that mutation drives disease. That terrain is something you can work with.

The question I ask every patient I work with is this: What conditions are you creating inside your body every single day? Because cancer does not arise in a vacuum, and it does not progress in one either. The most powerful thing you can do is to stop waiting for your biology to be managed for you and start participating in it with real intention and real information.

If that is how you want to approach your health, I would love to work with you.

Work with Dr. Lena

References

1. Baliakas P, Soussi T. The TP53 tumor suppressor gene: from molecular biology to clinical investigations. J Intern Med. 2025;298:78-98. doi:10.1111/joim.13926

2. Aggarwal M, Saxena R, Sinclair E, et al. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth. Cell Death Differ. 2016;23(10):1615-1627. doi:10.1038/cdd.2016.48

3. Wang YX, Wang LW, Huang Y, et al. Natural compound PEITC inhibits gain of function of p53 mutants in cancer cells by switching YAP-binding partners between p53 and p73. Acta Pharmacol Sin. 2025. doi:10.1038/s41401-025-01474-1

4. Hientz K, Mohr A, Bhakta-Guha D, Efferth T. The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget. 2017;8(5):8921-8946. doi:10.18632/oncotarget.13475

5. Min KJ, Kim HS, Park JW, Kwon TK. Fisetin induces apoptosis through p53-mediated up-regulation of DR5 expression in human renal carcinoma Caki cells. Molecules. 2018;23(9):2265. doi:10.3390/molecules23092265

6. Knizhnik AV, et al. Genotoxic and cytotoxic activity of fisetin on glioblastoma cells. Anticancer Res. 2024;44(3):901-912. doi:10.21873/anticanres.16878

7. Ahmadi F, et al. Fisetin as a chemoprotective and chemotherapeutic agent: mechanistic insights and future directions in cancer therapy. Med Oncol. 2025. doi:10.1007/s12032-025-02664-x

8. Shi R, Shen HM. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol Cancer Ther. 2007;6(4):1338-1347. doi:10.1158/1535-7163.MCT-06-0638

9. Chang X, Tamauchi S, Yoshida K, et al. Luteolin activates the p53 signaling pathway and suppresses tumor growth in high-grade serous ovarian cancer. Gynecol Oncol. 2023;173:111-120. doi:10.1016/j.ygyno.2023.04.007

10. Fan W, et al. Mechanism of luteolin against non-small-cell lung cancer via the Akt/MDM2/p53 signaling pathway. Front Oncol. 2024;14:1471109. doi:10.3389/fonc.2024.1471109

11. Carranca ME, et al. Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines. Redox Biol. 2019;28:101320. doi:10.1016/j.redox.2019.101320

12. Siddiqui FA, et al. Curcumin rescue p53Y220C in BxPC-3 pancreatic adenocarcinomas cell line. Biochim Biophys Acta Mol Cell Res. 2021;1868(3):118936. doi:10.1016/j.bbamcr.2020.118936

13. Parama D, et al. Curcumin mediates selective aggregation of mutant p53 in cancer cells. Biochem Biophys Res Commun. 2023;676:22-32. doi:10.1016/j.bbrc.2023.07.043

14. Jeon YJ, et al. Enhanced antitumor activity of vitamin C via p53 in cancer cells. Oncotarget. 2012;3(8):873-884. doi:10.18632/oncotarget.636

15. Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA. 2002;99(22):14548-14553. doi:10.1073/pnas.212319799

16. Rudolf E, Rudolf K, Cervinka M. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biochem Funct. 2008;26(5):561-567. doi:10.1002/cbf.1477

17. Memorial Sloan Kettering Cancer Center. Reishi mushroom: integrative medicine summary. mskcc.org/cancer-care/integrative-medicine/herbs/reishi-mushroom

Dr. Lena Suhaila is a naturopathic oncologist and the founder of Naturally Well Within. To learn more about her work, visit her About page.